潤貝航科(001316.SZ):公司是商飛的三類合格供應商
格隆匯6月2日丨有投資者在投資者互動平台向潤貝航科(001316.SZ)提問,“c919已經投入商業運行,請問貴公司為c919的運行提供了哪些服務?”
公司回覆稱,公司是商飛的三類合格供應商,主要為商飛提供航空材料、消耗件航空化學品等。在C919試驗機型的生產過程中我們已經為商飛提供了相關航材的供應。在自研航材板塊,公司子公司潤和新材料的部分國產化航材已經獲得中國商飛工藝材料產品批准書。國產大飛機向航司交付後,飛機日常運營過程中的維修保養由航司統籌安排,所用到的原廠航材將由航司或飛機維修公司向潤貝進行採購。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.